Iniparib, a PARP1 inhibitor for the potential treatment of cancer, including triple-negative breast cancer.
Year: 2010
Type: article
Source: PubMed
Authors: Hongyang Liang, Antoinette R Tan
Institution: Rutgers Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2413334570
